Menu
Menu
The Cushing’s Hub Editorial Board is delighted to announce the release of the webcast from the second event in the Cushing’s Hub Webinar Series – Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS) – held on Tuesday 24 October.
Chaired by Dr Susan M. Webb, Barcelona, Spain, this webcast sees panelists Assoc. Prof. Iacopo Chiodini, Milan, Italy and Dr Irina Bancos, Rochester, MN, USA, discuss, using a case-centred approach, the clinical management of low-grade excessive cortisol secretion and take questions from the audience.
The live event, and webcast, Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS), 24/10/23, have been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credit (ECMEC®).
This editorial discusses the recent changes to the ESE/ENSAT joint guidelines and invites you to attend the 2023 Cushing’s Hub webinar – Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS)
Differentiating between neoplastic and nonneoplastic hypercortisolaemia can be challenging. This Publication Highlight summarises work by Findling and Raff on the likelihood of cortisol excess having a neoplastic or nonneoplastic origin.
Experts emphasize the need for long-term surveillance for all patients with Cushing’s syndrome, after their systematic literature review showed associated comorbidities often continue well beyond remission.
